# Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode

> **NCT05384392** · NA · RECRUITING · sponsor: **University Hospital, Brest** · enrollment: 217 (estimated)

## Conditions studied

- First-episode Psychosis

## Interventions

- **OTHER:** Recorded interview
- **OTHER:** Clinical scales
- **BIOLOGICAL:** Blood sample

## Key facts

- **NCT ID:** NCT05384392
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-27
- **Primary completion:** 2027-03
- **Final completion:** 2030-03
- **Target enrollment:** 217 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05384392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05384392, "Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05384392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
